Theravance BiopharmaTBPH
那斯達克 · USD
17.68
+0.07
(+0.40%)
收盤 12/12 04:59 (UTC+8)
12/12 04:59 (UTC+8)
Theravance BiopharmaTBPH
17.68
+0.07
(+0.40%)
財務數據
損益表
- 0.14
- 0.16
- 0.18
- 0.15
- 0.14
- 0.17
- 0.19
- 0.15
- 0.26
- 0.20
- 31.99
- 14.14
- 11.93
- -17.43
- -1.70
- 18.32
- 11.18
- -17.95
- 70.23
- -23.69
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 19,990 | 26,195 | 15,388 | 18,754 | 16,868 | 14,256 | 14,503 | 17,565 | 15,693 | 13,749 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 19,990 | 26,195 | 15,388 | 18,754 | 16,868 | 14,256 | - | 17,565 | 15,693 | 13,749 |
營業費用 | 26,444 | 28,920 | 29,822 | 27,954 | 27,705 | 29,961 | - | 23,805 | 24,453 | 29,872 |
研發費用 | 8,112 | 10,490 | 11,452 | 9,453 | 9,268 | 9,954 | 8,968 | 8,313 | 8,311 | 9,425 |
推銷及管理費用 | 18,332 | 18,430 | 18,370 | 18,501 | 16,875 | 17,056 | 16,742 | 15,492 | 16,142 | 19,278 |
非經常性項目費用 | - | - | - | - | 1,562 | 2,951 | - | - | - | 1,169 |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -6,454 | -2,725 | -14,434 | -9,200 | -10,837 | -15,705 | -11,207 | -6,240 | -8,760 | -16,123 |
其他收入及費用 | 4,138 | 76,594 | 939 | 904 | 1,415 | 1,128 | 1,434 | 1,847 | 1,786 | 2,504 |
利息費用 | 573 | 663 | 643 | 643 | 630 | 644 | 629 | 623 | 609 | 568 |
稅前純益 | -2,889 | 73,206 | -14,138 | -8,939 | -10,052 | -15,221 | -10,402 | -5,016 | -7,583 | -14,187 |
所得稅 | -6,504 | 18,371 | -559 | 6,588 | 2,646 | 1,308 | 1,262 | 3,494 | 1,367 | 1,458 |
稅後純益 | 3,615 | 54,835 | -13,579 | -15,527 | -12,698 | -16,529 | -11,664 | -8,510 | -8,950 | -15,645 |
基本每股稅後盈餘(元) | 0.07 | 1.09 | -0.27 | -0.31 | -0.26 | -0.34 | -0.24 | -0.17 | -0.17 | -0.28 |
稀釋每股稅後盈餘(元) | 0.07 | 1.08 | -0.27 | -0.31 | -0.26 | -0.34 | -0.24 | -0.19 | -0.18 | -0.28 |
基本平均股數(千股) | 50520.00 | 50177.00 | 49706.00 | 49306.00 | 49038.00 | 48747.00 | 48283.00 | 49415.00 | 52361.00 | 56682.00 |
稀釋平均股數(千股) | 51908.00 | 50726.00 | 49706.00 | 49306.00 | 49038.00 | 48747.00 | 48283.00 | 49415.00 | 52361.00 | 56682.00 |
還原基本每股稅後盈餘(元) | 0.07 | 1.09 | -0.27 | -0.31 | -0.26 | -0.34 | -0.24 | -0.17 | -0.17 | -0.28 |
還原稀釋每股稅後盈餘(元) | 0.07 | 1.08 | -0.27 | -0.31 | -0.26 | -0.34 | -0.24 | -0.19 | -0.18 | -0.28 |
還原基本平均股數(千股) | 50,520 | 50,177 | 49,706 | 49,306 | 49,038 | 48,747 | 48,283 | 49,415 | 52,361 | 56,682 |
還原稀釋平均股數(千股) | 51,908 | 50,726 | 49,706 | 49,306 | 49,038 | 48,747 | 48,283 | 49,415 | 52,361 | 56,682 |
EBITDA(千元) | -1,680 | 74,796 | -12,443 | -7,601 | -8,660 | -13,598 | -8,594 | -2,976 | -6,037 | -12,695 |